
The study reports NHS England data for patients with bladder cancer (BC), upper tract urothelial cancer (UTUC), and urethral cancers from 2013 to 2019. Incidence rates were stable. About 41.3% of patients were referred outside the 2‐week‐wait pathway, and 12.2% presented as emergencies. Surgery, radiotherapy, chemotherapy, or multimodal treatment use varied with disease stage, patient factors and Cancer Alliance. Between 27% and 29% of muscle‐invasive BCs did not receive radical treatment. Overall survival rates did not improve over time at 2 years in contrast to other cancers. NHS Digital data offers a population‐wide picture of this disease but does not allow individual outcomes to be matched with disease or patient features, and key parameters can be missing or incomplete.
Like
Save
Share